Generics – Healthy Skeptic

May 23 2011

NPR.org

By Kevin Roche Headlines No Comments

Three-quarters of prescriptions these days are filled with a generic. And the proportion keeps climbing.

May 20 2011

NPR.org

By Kevin Roche Headlines No Comments

Three-quarters of prescriptions these days are filled with a generic. And the proportion keeps climbing.

May 05 2011

Chicago Tribune

By Kevin Roche Headlines No Comments

Some of the top-selling drugs in the U.S. — including Lipitor, Plavix and Actos — will lose patent protection in the coming years, promising big savings for consumers

May 05 2011

Fox Business

By Kevin Roche Headlines No Comments

The Federal Trade Commission has found an “unprecedented” 60% jump in drug industry”pay for delay” deals that stall consumers’ access to cheaper generic drugs, hurting consumers’ and taxpayers’ wallets.

Jul 08 2010

HealthLeaders Media

By Kevin Roche Headlines No Comments

Restrictions on “pay-to-delay” (limiting drug manufacturers’ abilities to keep generic medicines off the market) were excluded in the final Senate bill – last week the House approved an amendment to curb such practices.

Jun 08 2010

Wall Street Journal

By Kevin Roche Headlines No Comments

A review out today from Avalere Health, a research and consulting firm, drills down into states’ (and D.C.’s) generic dispensing policies

Jan 15 2010

Washington Post

By Kevin Roche Headlines No Comments

A LOOPHOLE in existing law allows manufacturers of brand-name drugs to pay competitors to keep cheaper, generic versions off the market